India Rejects HIV Drug Application By Abbott Laboratories

4 Jan 2011

India, over the New Year weekend, has rejected an unmerited HIV drug patent application by US drug giant Abbott Laboratories, paving the way for access to lifesaving medication for HIV patients across the world. Read full story here.

Partner with us now to build
a more just and equitable
medicine system for all.